|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.82 USD | +0.23% |
|
-16.77% | -15.14% |
| 05-14 | Transcript : Curis, Inc. - Special Call | |
| 05-14 | Curis, Inc. Announces Additional Data from Take Aim Leukemia Study | CI |
Curis, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was USD 2.09 million compared to USD 2.3 million a year ago. Net loss was USD 11.88 million compared to USD 11.56 million a year ago.
Basic loss per share from continuing operations was USD 2.05 compared to USD 2.39 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -15.14% | 63.77M | |
| +64.23% | 62.59B | |
| -2.31% | 41.18B | |
| +44.36% | 40.29B | |
| -8.29% | 27.9B | |
| +11.97% | 26.21B | |
| -21.16% | 19.09B | |
| +7.54% | 13.08B | |
| +27.17% | 12.05B | |
| +25.72% | 12.26B |
CURIS, INC. 
